Literature DB >> 24637258

Clinically relevant concentrations of ketamine mainly affect long-term potentiation rather than basal excitatory synaptic transmission and do not change paired-pulse facilitation in mouse hippocampal slices.

Patrícia O Ribeiro1, Angelo R Tomé2, Henrique B Silva3, Rodrigo A Cunha4, Luís M Antunes5.   

Abstract

Ketamine, an analgesic/anesthetic drug, is increasingly popular in clinical practice due to its analgesic properties and importance for emergency procedures. The impact of ketamine on basal excitatory synaptic transmission and synaptic plasticity are not yet fully understood. Therefore we investigated the effects of different concentrations of ketamine on basal excitatory synaptic transmission and on two forms of synaptic plasticity: paired-pulse facilitation (PPF) and long-term potentiation (LTP). Evoked field excitatory postsynaptic potentials (fEPSP) were recorded in Schaffer fiber - CA1 pyramid synapses of mouse hippocampal slices and the initial slope of the fEPSP was measured to estimate the percentage of inhibition of the basal synaptic transmission. Presynaptic volley amplitude, PPF and LTP induction and maintenance were also calculated. For basal synaptic transmission and PPF increasing concentrations of ketamine (1, 3, 10, 30, 100, 200, 300 and 600μM) were applied to each slice and for LTP individual slices were used for each concentration (3, 10, 30 or 100μM). Clinically relevant concentrations of ketamine decreased LTP in a concentration-dependent manner without changing PPF, whereas basal excitatory synaptic transmission and presynaptic volley amplitude was affected only with high concentrations of ketamine (300 and 600μM). These results allow dissociating the blockade of LTP from a reduced synaptic input in the action of clinically relevant concentrations of ketamine in the CA1 region of the mouse hippocampus. Moreover, this work shows that the effects of ketamine on LTP and on basal synaptic transmission are dependent of the concentration used.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hippocampus; Ketamine; Synaptic plasticity; Synaptic transmission

Mesh:

Substances:

Year:  2014        PMID: 24637258     DOI: 10.1016/j.brainres.2014.03.004

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Increasing doses of ketamine curtail antidepressant responses and suppress associated synaptic signaling pathways.

Authors:  Ji-Woon Kim; Lisa M Monteggia
Journal:  Behav Brain Res       Date:  2019-11-21       Impact factor: 3.332

2.  Neonatal exposure of ketamine inhibited the induction of hippocampal long-term potentiation without impairing the spatial memory of adult rats.

Authors:  Dongyong Guo; Jianhui Gan; Tao Tan; Xin Tian; Guolin Wang; Kevin Tak-Pan Ng
Journal:  Cogn Neurodyn       Date:  2018-02-22       Impact factor: 5.082

3.  Transcranial focused ultrasound induces sustained synaptic plasticity in rat hippocampus.

Authors:  Xiaodan Niu; Kai Yu; Bin He
Journal:  Brain Stimul       Date:  2022-01-30       Impact factor: 9.184

4.  Chronic administration of ketamine induces cognitive deterioration by restraining synaptic signaling.

Authors:  Yayan Luo; Yang Yu; Minling Zhang; Hongbo He; Ni Fan
Journal:  Mol Psychiatry       Date:  2020-06-02       Impact factor: 15.992

5.  Ketamine Protects Gamma Oscillations by Inhibiting Hippocampal LTD.

Authors:  Lanting Huang; Xiu-Juan Yang; Ying Huang; Eve Y Sun; Mu Sun
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

6.  Effect of Ketamine on LTP and NMDAR EPSC in Hippocampus of the Chronic Social Defeat Stress Mice Model of Depression.

Authors:  Yu Yang; Weina Ju; Haining Zhang; Li Sun
Journal:  Front Behav Neurosci       Date:  2018-10-09       Impact factor: 3.558

7.  Ketamine and its metabolite, (2R,6R)-HNK, restore hippocampal LTP and long-term spatial memory in the Wistar-Kyoto rat model of depression.

Authors:  Lily R Aleksandrova; Yu Tian Wang; Anthony G Phillips
Journal:  Mol Brain       Date:  2020-06-16       Impact factor: 4.041

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.